SAUDI ARABIA

Health official warns against unsupervised use of weight-loss drugs like Ozempic, Mounjaro

July 15, 2025

Saudi Gazette report

RIYADH — Saudi Deputy Minister of Health for Population Health, Dr. Abdullah Asiri, has issued a public warning against the unsupervised use of anti-obesity medications such as Ozempic and Mounjaro, emphasizing the serious health risks associated with misuse.

In a post on his official X account, Dr. Asiri cautioned that reckless reliance on these drugs or drastic dietary changes — such as extreme calorie restriction or rigid vegan diets — can result in nutritional imbalances that negatively affect overall health.

He noted that dietary supplements are generally unnecessary when one follows a well-balanced and complete diet.

He also advised the public to avoid foods high in fat and irritating spices, and to incorporate regular physical activity, such as walking and exercise, into their daily routines to maintain a healthy lifestyle without resorting to quick fixes or risky solutions.

His remarks come amid growing concern from medical professionals about the increasing popularity of weight-loss drugs being used without prescriptions, raising red flags over long-term safety and potential side effects.


July 15, 2025
3075 views
HIGHLIGHTS
SAUDI ARABIA
55 minutes ago

Saudi Armed Forces take part in Bright Star 2025 exercise in Egypt

SAUDI ARABIA
hour ago

Arab-Islamic Committee asks US to reverse decision not to grant visas for Palestinian delegation

SAUDI ARABIA
2 hours ago

FII9 in Riyadh to spotlight prosperity and investment